이 페이지는 자동 번역되었으며 번역의 정확성을 보장하지 않습니다. 참조하십시오 영문판 원본 텍스트의 경우.

Posterior Versus Transmuscular Quadratus Lumborum Block in Children Undergoing Lower Abdominal Surgery

2026년 11월 3일 업데이트: Kerollos Moneer Neseem Mikhael, Beni-Suef University

Analgesic Efficacy of Posterior Versus Transmuscular Quadratus Lumborum Block in Children Undergoing Unilateral Lower Abdominal Surgery: A Randomized Controlled Trial

The quadratus lumborum block (QLB) is an established regional anesthesia technique that provides somatic and visceral analgesia for abdominal wall procedures in both adult and pediatric populations. Among its standardized approaches, the posterior QLB (QL2-injectate deposited in the lumbar interfascial triangle at the posterior surface of the quadratus lumborum muscle) and the transmuscular QLB (QL3-injectate deposited in the fascial plane between the anterior surface of the quadratus lumborum and psoas major muscles) are widely utilized.

Although cadaveric and radiological studies suggest that transmuscular QLB yields greater anterior and thoracic paravertebral spread compared to the posterior approach, comparative clinical evidence in pediatric populations remains limited.

The objective of this randomized, prospective, double-blind controlled trial is to compare the analgesic efficacy of ultrasound-guided posterior QLB (QL2) versus transmuscular QLB (QL3) using an identical weight-based dose and concentration of local anesthetic (0.4 mL/kg of bupivacaine 0.25%) in children aged 1 to 7 years undergoing elective unilateral lower abdominal surgery (e.g., inguinal herniotomy, orchiopexy, hydrocelectomy). The primary hypothesis is that one approach will provide superior 24-hour cumulative opioid-sparing analgesia compared to the other.

연구 개요

상세 설명

Background and Anatomical Rationale:

Truncal fascial plane blocks like the quadratus lumborum block (QLB) play a key role in pediatric multimodal analgesia. While posterior QLB (QL2) targets the lumbar interfascial triangle (LIFT) with minimal anatomical risk to deep structures, transmuscular QLB (QL3) penetrates the QL muscle to deposit local anesthetic in the anterior fascial plane adjacent to the psoas major muscle. This study evaluates whether these anatomical differences translate into distinct clinical analgesic outcomes in pediatric patients.

Anesthetic Protocol and Block Execution:

Following standardized general anesthesia induction and airway securing, children assigned to either group receive an ultrasound-guided unilateral block in the lateral decubitus position using the classic "Shamrock" sonographic landmark view (L3 transverse process level).

Posterior QLB Group (QL2): A short-bevel echogenic needle is advanced in-plane to the posterior aspect of the quadratus lumborum muscle (QLM) within the lumbar interfascial triangle.

Transmuscular QLB Group (QL3): An identical needle is advanced transmuscularly through the QLM into the fascial plane between the anterior surface of the QL and psoas major muscle.

In both groups, plane identification is confirmed by hydrodissection (1-2 mL saline/D5W), followed by slow injection of 0.4 mL/kg bupivacaine 0.25% (1 mg/kg; maximum 20 mL) with intermittent aspiration every 3-5 mL.

Postoperative Analgesic Management and Assessment:

Postoperative behavioral pain intensity is monitored by a blinded observer using the Face, Legs, Activity, Cry, Consolability (FLACC) score at 0 (PACU arrival), 1, 2, 4, 6, 12, 18, and 24 hours postoperatively. Stepwise rescue analgesia is initiated for FLACC scores ≥4: intravenous paracetamol 15 mg/kg (if >6 hours from prior dose), followed by rescue intravenous fentanyl 0.5 µg/kg or morphine 0.05 mg/kg if pain persists.

Sedation (University of Michigan Sedation Scale), motor block (modified Bromage scale), time to first rescue request, incidence of postoperative nausea and vomiting (PONV), parental satisfaction (5-point Likert scale), and time to post-anesthesia discharge readiness are systematically evaluated.

연구 유형

중재적

등록 (추정된)

70

단계

  • 해당 없음

연락처 및 위치

이 섹션에서는 연구를 수행하는 사람들의 연락처 정보와 이 연구가 수행되는 장소에 대한 정보를 제공합니다.

연구 연락처

연구 장소

      • Banī Suwayf, 이집트
        • Beni-Suef University Hospital

참여기준

연구원은 적격성 기준이라는 특정 설명에 맞는 사람을 찾습니다. 이러한 기준의 몇 가지 예는 개인의 일반적인 건강 상태 또는 이전 치료입니다.

자격 기준

공부할 수 있는 나이

1년 (어린이)

건강한 자원 봉사자를 받아들입니다

아니

연구 대상 성별

모두

설명

Inclusion Criteria:

Children aged 1 to 7 years. American Society of Anesthesiologists (ASA) physical status I or II. Scheduled for elective unilateral lower abdominal surgery under general anesthesia with a planned quadratus lumborum block for postoperative analgesia (e.g., inguinal herniotomy, orchiopexy, hydrocelectomy).

Written informed consent obtained from a parent or legal guardian.

Exclusion Criteria:

Parental or guardian refusal to participate. Known allergy or hypersensitivity to amide local anesthetics. Coagulopathy or active use of anticoagulant or antiplatelet medication. Local skin infection at the intended regional block injection site. Planned bilateral surgical procedure. Significant hepatic, renal, cardiac, or neuromuscular disease. Developmental delay or medical condition precluding reliable pain-scale assessment.

Preoperative chronic opioid or regular analgesic use. Body weight below the 3rd percentile for age, or known spinal/vertebral column anomaly precluding safe block performance.

Emergency surgery.

공부 계획

이 섹션에서는 연구 설계 방법과 연구가 측정하는 내용을 포함하여 연구 계획에 대한 세부 정보를 제공합니다.

연구는 어떻게 설계됩니까?

디자인 세부사항

  • 주 목적: 치료
  • 할당: 무작위
  • 중재 모델: 병렬 할당
  • 마스킹: 삼루타

무기와 개입

참가자 그룹 / 팔
개입 / 치료
활성 비교기: Posterior QLB (QL2)

Children assigned to this arm receive a single-dose, ultrasound-guided posterior quadratus lumborum block (QL2) performed after induction of general anesthesia and prior to surgical incision. Under ultrasound guidance, a short-bevel echogenic needle is advanced to the posterior surface of the quadratus lumborum muscle within the lumbar interfascial triangle (LIFT). Local anesthetic is deposited following hydrodissection confirmation and negative aspiration.

Ultrasound-guided single-injection posterior quadratus lumborum block performed pre-incisions under general anesthesia. Local anesthetic: 0.4 mL/kg of bupivacaine 0.25% (1 mg/kg; maximum single-side volume 20 mL) deposited at the posterior border of the QL muscle within the lumbar interfascial triangle.

다른 이름들:
  • QL2 block
  • Lumbar interfascial triangle block
활성 비교기: Transmuscular QLB (QL3)

Children assigned to this arm receive a single-dose, ultrasound-guided transmuscular quadratus lumborum block (QL3) performed after induction of general anesthesia and prior to surgical incision. Under ultrasound guidance using the "Shamrock" view, a short-bevel needle is advanced transmuscularly through the quadratus lumborum muscle to deposit local anesthetic in the fascial plane between its anterior surface and the psoas major muscle following hydrodissection confirmation and negative aspiration.

Ultrasound-guided single-injection transmuscular quadratus lumborum block performed pre-incisions under general anesthesia. Local anesthetic: 0.4 mL/kg of bupivacaine 0.25% (1 mg/kg; maximum single-side volume 20 mL) deposited in the plane between the anterior surface of the QL muscle and psoas major muscle.

다른 이름들:
  • Anterior/Lateral QLB
  • Shamrock approach QLB

연구는 무엇을 측정합니까?

주요 결과 측정

결과 측정
측정값 설명
기간
Total Cumulative Opioid Consumption in the First 24 Hours
기간: First 24 hours postoperatively

Total cumulative dose of intraoperative and postoperative rescue opioids administered during the first 24 hours postoperatively, converted to intravenous morphine-equivalent doses (mg/kg) using standard conversion ratios and normalized to body weight. A lower numerical value indicates a superior clinical outcome (greater opioid-sparing effect and reduced opioid requirement).

First 24 hours postoperatively

2차 결과 측정

결과 측정
측정값 설명
기간
Postoperative Pain Intensity Scores
기간: At 0 (PACU arrival), 1, 2, 4, 6, 12, 18, and 24 hours postoperatively

Postoperative pain intensity measured using the Face, Legs, Activity, Cry, Consolability (FLACC) behavioral pain scale. Scores range from 0 to 10, where 0 represents no pain (relaxed and comfortable; best outcome) and 10 represents severe pain/discomfort (worst outcome). Lower numerical scores represent better pain control.

At 0 (PACU arrival), 1, 2, 4, 6, 12, 18, and 24 hours postoperatively
Time to First Rescue Analgesia Request
기간: Up to 24 hours postoperatively

Time elapsed (in minutes) from arrival in the Post-Anesthesia Care Unit (PACU) until the first administration of rescue analgesic (triggered by a FLACC score ≥4). A higher numerical value (longer duration of time) indicates a superior clinical outcome (prolonged block duration and delayed pain onset).

Up to 24 hours postoperatively
Block Execution Time
기간: Intraoperatively (during block performance)

Total time required to perform the ultrasound-guided regional block, measured in seconds from initial placement of the ultrasound transducer on the skin to needle withdrawal. Lower execution times represent greater technical ease and efficiency (better procedural performance).

Intraoperatively (during block performance)
Number of Needle Passes and Redirections
기간: Intraoperatively (during block performance)

Number of discrete needle skin punctures and forward redirections required to achieve correct needle tip positioning within the intended target fascial plane. A lower count indicates easier needle placement and less tissue trauma (better procedural outcome).

Intraoperatively (during block performance)
Incidence and Severity of Postoperative Nausea and Vomiting
기간: At 0, 1, 2, 4, 6, 12, 18, and 24 hours postoperatively

Presence and severity of postoperative nausea and vomiting assessed using a 4-point scale (0 = no nausea or vomiting [best outcome], 1 = mild nausea, 2 = moderate nausea or single emetic episode, 3 = severe nausea or multiple emetic episodes requiring antiemetic rescue [worst outcome]). Lower scores represent a better clinical outcome.

At 0, 1, 2, 4, 6, 12, 18, and 24 hours postoperatively
Postoperative Sedation Score
기간: At 0, 1, 2, 4, 6, 12, 18, and 24 hours postoperatively

Sedation level evaluated using the University of Michigan Sedation Scale (UMSS), ranging from 0 (awake and alert; normal state) to 4 (unarousable to noxious stimuli; severe sedation/respiratory risk). Lower scores (specifically 0 to 1) represent desirable postoperative alertness and faster recovery.

At 0, 1, 2, 4, 6, 12, 18, and 24 hours postoperatively
Incidence and Degree of Lower Limb Motor Blockade
기간: At 1, 4, and 8 hours postoperatively

Motor weakness evaluated using a modified Bromage scale (0 = full flexion of knees and feet / no motor block [best safety outcome], 1 = partial flexion, 2 = movement of feet only, 3 = complete paralysis of lower limb [worst outcome]). A score of 0 indicates an optimal motor-sparing sensory block without unwanted lumbar plexus involvement.

At 1, 4, and 8 hours postoperatively
Parental Satisfaction Score
기간: 24 hours postoperatively

Parental or legal guardian overall satisfaction with post-surgical pain management evaluated on a 5-point Likert scale (1 = very dissatisfied [worst outcome], 2 = dissatisfied, 3 = neutral, 4 = satisfied, 5 = very satisfied [best outcome]). Higher numerical scores represent a superior clinical outcome.

24 hours postoperatively
Time to Post-Anesthesia Discharge Readiness
기간: Up to 24 hours postoperatively

Time elapsed (in minutes) from PACU arrival until the child satisfies all criteria of the modified pediatric Post-Anesthesia Discharge Scoring System (PADSS). A lower numerical value (shorter duration of time in minutes) indicates a better outcome (faster recovery and earlier discharge readiness).

Up to 24 hours postoperatively
Incidence of Block-Related Adverse Events and Complications
기간: Through 24 hours postoperatively

Total count and percentage of procedural complications (including vascular puncture, LAST, peritoneal injury, localized hematoma, or infection). A lower number (ideally 0) indicates a superior safety profile.

Through 24 hours postoperatively

공동 작업자 및 조사자

여기에서 이 연구와 관련된 사람과 조직을 찾을 수 있습니다.

연구 기록 날짜

이 날짜는 ClinicalTrials.gov에 대한 연구 기록 및 요약 결과 제출의 진행 상황을 추적합니다. 연구 기록 및 보고된 결과는 공개 웹사이트에 게시되기 전에 특정 품질 관리 기준을 충족하는지 확인하기 위해 국립 의학 도서관(NLM)에서 검토합니다.

연구 주요 날짜

연구 시작 (추정된)

2026년 11월 1일

기본 완료 (추정된)

2027년 4월 1일

연구 완료 (추정된)

2027년 5월 1일

연구 등록 날짜

최초 제출

2026년 11월 3일

QC 기준을 충족하는 최초 제출

2026년 11월 3일

처음 게시됨 (실제)

2026년 11월 9일

연구 기록 업데이트

마지막 업데이트 게시됨 (실제)

2026년 11월 9일

QC 기준을 충족하는 마지막 업데이트 제출

2026년 11월 3일

마지막으로 확인됨

2026년 11월 1일

추가 정보

이 연구와 관련된 용어

개별 참가자 데이터(IPD) 계획

개별 참가자 데이터(IPD)를 공유할 계획입니까?

예

IPD 계획 설명

De-identified individual participant data (including primary outcome measures, demographic variables, FLACC pain scores, cumulative opioid consumption, and block execution metrics) will be made available to qualified academic researchers upon reasonable request submitted to the principal investigator, following publication of the primary trial results.

IPD 공유 기간

Data will become available 3 months following peer-reviewed journal publication of the primary manuscript and will remain accessible for 3 years.

IPD 공유 액세스 기준

Data will be shared with recognized medical and academic researchers who submit a sound scientific proposal and a signed data-use agreement to the principal investigator (at Kmnmk87@med.bsu.edu.eg).

IPD 공유 지원 정보 유형

  • 연구_프로토콜
  • 수액

약물 및 장치 정보, 연구 문서

미국 FDA 규제 의약품 연구

아니

미국 FDA 규제 기기 제품 연구

아니

이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .

구독하다